PCOC
JAZZ icon

Power Corp of Canada’s Jazz Pharmaceuticals JAZZ Stock Holding History

Power Corp of Canada’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,643
Closed -$2.93M – 185
2023
Q3 		$2.93M Hold
22,643
– – 0.19% 95
2023
Q2 		$2.81M Hold
22,643
– – 0.28% 98
2023
Q1 		$3.2M Buy
22,643
+11,106
+96% +$1.64M 0.33% 95
2022
Q4 		$1.84M Hold
11,537
– – 0.33% 77
2022
Q3 		$1.54M Hold
11,537
– – 0.36% 80
2022
Q2 		$1.8M Buy
11,537
+337
+3% +$51.9K 0.37% 43
2022
Q1 		$1.74M Buy
+11,200
New +$1.63M 0.15% 94

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Power Corp of Canada's JAZZ Position: Q4 2023 in Review

Power Corp of Canada sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 22,643 shares — an estimated $2.93M sold.

Power Corp of Canada first reported a position in JAZZ in Q1 2022 and held it in 7 quarters. The position peaked at $3.2M in Q1 2023. 499 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

  • Power Corp of Canada reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Power Corp of Canada sold 22,643 Jazz Pharmaceuticals shares in Q4 2023, an estimated $2.93M.
  • Power Corp of Canada first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 7 quarters.
  • Power Corp of Canada's Jazz Pharmaceuticals position peaked at $3.2M in Q1 2023.
  • 499 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on Power Corp of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.